NEWS

Debate Over Whether Biologics Constitute Natural Monopolies Continues

Debate Over Whether Biologics Constitute Natural Monopolies Continues

“Peter B. Bach, MD, a well-known critic of high drug prices, along with Jennifer A. Ohn, MPH, Preston Atteberry, MD, and Mark Trusheim, MSc, first wrote in April that biosimilar competition is an economically inefficient way to achieve the goal of lower prices; the biosimilar environment is different than the one that exists in the generic marketplace for small-molecule drugs. These authors said, instead, that biosimilars are natural monopolies and as such need price regulation in order for them to succeed and for prices to come down.”

read more
MGA’s Alex Brill on CNBC’s Squawk Box

MGA’s Alex Brill on CNBC’s Squawk Box

“I think its a solid [GDP] number. Obviously the inventory piece creates a little bit of volatility and the investment numbers are a disappointment, but not a surprise. Overall we see a strong consumers. On the Fed, I would agree with Austin. What the Fed has to do now more than ever is try to block out the political noise, focus on the data and make the best call to boost their credibility or sustain their credibility.”

read more
Shortened Exclusivity Could Save $31B

Shortened Exclusivity Could Save $31B

“Brand-name medicines’ market exclusivity periods have climbed an average of 2.2 years since the mid-1990s, steadily delaying the market arrival of generic rivals. Reversing that trend alone could save the U.S. health care system roughly $31.7 billion, according to a Matrix report commissioned by the Coalition for Affordable Prescription Drugs, a group of insurers, pharmacy benefit managers and large employers.”

read more
Biologics are Not Natural Monopolies

Biologics are Not Natural Monopolies

Recently, several physicians and health policy analysts took to the Health Affairs blog to propose what was, to anyone who has been following biosimilars for the last decade or more, a surprising and concerning idea: that biosimilars should be abandoned.

read more
2018 Charitable Giving Dips, as Predicted

2018 Charitable Giving Dips, as Predicted

A Giving USA report released last week shows that US households’ charitable donations in 2018 experienced the largest decline since the Great Recession. We hate to say we told you so, but we told you so.

read more
MGA’s Alex Brill on CNBC’s Squawk Box

MGA’s Alex Brill on CNBC’s Squawk Box

The fourth quarter economic reports show less growth than expected. Brill shares his opinion that “things are slowing a little bit around the world and its a little bit of a timing effect between the seasonal issues that we know and the shutdown issues as well.”

read more

Have a Question?

Get In Touch

Get Our latest news

subscribe

Address

1350 Connecticut Avenue NW
Suite 610
Washington, DC 20036

Follow Us